 AlphaCrest Capital Management LLC cut its holdings in shares of China Biologic Products Holdings Inc NASDAQ:CBPO by 64.2 during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,800 shares of the biopharmaceutical companys stock after selling 8,600 shares during the quarter. AlphaCrest Capital Management ... 